Skip to main content
Our Work

Applying Big Data to Address the Social Determinants of Health in Oncology: A Workshop

Completed

Topics

This workshop, held in collaboration with the Committee on Applied and Theoretical Statistics, examined the social determinants of health in the context of cancer and considered opportunities to effectively leverage big data to improve health equity and reduce disparities. Workshop presentations and discussions reviewed the social determinants of health and their influence on cancer risk and outcomes; novel data sources and methodologies; data policy and ethical considerations regarding the use of big data; opportunities for collaboration and data sharing; and assessing research gaps and suggestions for a research agenda.

About Past Events

Description

An ad hoc committee will plan and host a 1.5-day public workshop that will examine health equity and the social determinants of health in the context of cancer, and consider opportunities to effectively use big data and convergence science to improve health outcomes and reduce disparities. The workshop will feature invited presentations and panel discussions on topics that may include:

  • The impact of social determinants of health on cancer incidence and outcomes
  • Ways to capture precise and meaningful data on social determinants of health in oncology (social omics)
  • Potential biomarkers of environmental and social factors that may affect cancer incidence and care outcomes (e.g., microbiome, exposome, and epigenome)
  • The potential advantages and limitations of various methods for identifying geographic populations and communities at risk (e.g., state, county, zip code, city ward, or congressional district)
  • Potential opportunities to reduce bias in capturing big data and applying computational methods to inform cancer care
  • Examples of how community engagement and big data could be used to inform policies to promote health equity in oncology

The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.

Contributors

Committee

Robert A. Winn

Chair

Garnet L. Anderson

Member

Kenneth C. Anderson

Member

Karen Basen-Engquist

Member

Otis W. Brawley

Member

Nicole F. Dowling

Member

Stanton L. Gerson

Member

Lori Hoffman Hogg

Member

Nicholas Horton

Member

Ronald M. Kline

Member

Rebecca Miksad

Member

Timothy Rebbeck

Member

Victoria Seewaldt

Member

George J. Weiner

Member

Robin Yabroff

Member

Erin Balogh

Staff Officer

Download all bios

Sponsors

American Association for Cancer Research

American Cancer Society

American College of Radiology

American Society of Clinical Oncology

Association of American Cancer Institutes

Association of Community Cancer Centers

Bristol Myers Squibb

Cancer Support Community

Centers for Disease Control and Prevention (CDC)

CEO Roundtable on Cancer

Flatiron Health

Helsinn Therapeutics (U.S.), Inc.

Merck

National Comprehensive Cancer Network

National Institutes of Health

National Institutes of Health/National Cancer Institute

Novartis Oncology

Oncology Nursing Society

Pfizer Inc.

Staff

Erin Balogh

Lead

Sharyl Nass

Lead

Annalee Espinosa Gonzales

Emily Zevon

Ruth Cooper

Katherine Hawthorne

More like this

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.